Resource Center

More information?
More information?
Leave blank for all
Leave blank for all
To see all resources, click Reset
1000 RESULTS FOUND
AdvaMed Guiding Principles for Direct to Consumer (DTC) Device Advertising
April 23, 2019 | FAQs
Guiding Principles for Direct to Consumer Device Advertising
April 23, 2019 | White Paper
GMTA Market Access Subcommittee
April 18, 2019 |
GMTA General Assembly
April 18, 2019 |
Device Tax Campaign Graphic
April 9, 2019 |
AdvaMed 2019-2021 Committee and Board Chairs
March 26, 2019 |
Medical Device Tax: Claims vs. Facts
March 12, 2019 | Fact Sheet
Re: Docket No. FDA-2013-D-1445; Draft Guidance for Industry and FDA Staff on Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use
February 28, 2019 |
Re: Docket No. FDA-2013-D-1446; Draft Guidance for Industry and FDA Staff on SelfMonitoring Blood Glucose Test Systems for Over-the-Counter Use
February 28, 2019 |
Re: Docket No. FDA-2017-D-5570; Draft Guidance on Select Updates for Recommendations for CLIA of 1988 Waiver Applications for Manufacturers of IVD Devices
February 27, 2019 |
Re: Docket No. FDA-2017-D-5625; Draft Guidance on Recommendations for Dual 510(k) and CLIA Waiver by Application Studies
February 27, 2019 |
Docket No. FDA-2018-N-3741: Request for Comments on Medical Device Servicing and Remanufacturing Activities; Public Workshop Docket No. FDA-2018-N-3741-0001: White Paper: Evaluating Whether Activities are Servicing or Remanufacturing
February 26, 2019 |
AdvaMedDx VALID ACT Comments
February 15, 2019 | Comments
AdvaMedDx VALID Act Comments Overview
February 15, 2019 |
Docket No. FDA-2018-N-2727; RIN 0910-AH52: Institutional Review Board Waiver or Alteration of Informed Consent for Minimal Risk Clinical Investigations
February 13, 2019 | Comments
Cosponsor the Protect Medical Innovation Act of 2019
February 13, 2019 |
University Technology Transfer Best Practices Guide
February 12, 2019 | White Paper
Docket No. FDA-2018-D-3380-0001: Developing and Labeling In Vitro Companion Diagnostic Devices for a Specific Group or Class of Oncology Therapeutic Products; Draft Guidance for Industry; Availability
February 5, 2019 | Comments
AdvaMed Proposed Legislation - January 25, 2019
January 25, 2019 |
AdvaMed Comments on Licensing Requirements for Implantable Medical Devices Manufactured by 3D Printing; Draft Guidance
January 8, 2019 | Comments
Fact Check: Washington Post - Jeanne Lenzer and Shannon - The FDA is Still Letting Doctors Implant Untested Devices into Our Bodies
January 4, 2019 |
Memo on Medical Technology Artificial Intelligence (AI) in China
January 1, 2019 | White Paper
AdvaMed Comments on Docket No. FDA-2008-D-0180 Coronary Drug Eluting Stents Nonclinical and Clinical Studies
December 21, 2018 | Comments
AdvaMed Comments on Docket No. FDA-2018-N-3519: Collaborative Communities Toolkit
December 17, 2018 | Comments
AdvaMed Comments on Docket No. FDA-2016-D-2565
December 13, 2018 | Comments

Pages